Kometer, Michael <br/><br/>
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.  [electronic resource] 

 -  Biological psychiatry  Mar 2011 
 - 399-406 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2402 
<br/><br/><label>Standard No.: </label>10.1016/j.biopsych.2010.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cluster Analysis<br/>Consciousness Disorders--psychology<br/>Dose-Response Relationship, Drug<br/>Electroencephalography--drug effects<br/>Female<br/>Hallucinogens--pharmacology<br/>Humans<br/>Male<br/>Neuropsychological Tests<br/>Occipital Lobe--drug effects<br/>Parkinson Disease--complications<br/>Perceptual Closure--physiology<br/>Photic Stimulation<br/>Psilocybin--pharmacology<br/>Psychometrics<br/>Reaction Time--physiology<br/>Receptor, Serotonin, 5-HT1A--drug effects<br/>Receptor, Serotonin, 5-HT2A--drug effects<br/>Schizophrenia--complications<br/>Serotonin Receptor Agonists--pharmacology<br/>Visual Cortex--drug effects